Literature DB >> 15555887

In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci.

Jong-Bae Kim1, Gyu-Sang Lee, Yun-Bong Kim, Soo-Kie Kim, Yong Hae Kim.   

Abstract

The in vitro inhibitory and bactericidal activity of echinomycin and its the novel synthetic analogues of echinomycin,YK2000 and YK2005, were evaluated using 93 clinical isolates of vancomycin-resistant enterococci (VRE). In agar dilution tests, the MIC(90) of echinomycin and YK2000 were 0.125 and 8 mg/l, respectively, using Mueller-Hinton II agar, while that of YK2005 was 32 mg/l. Bactericidal activity of echinomycin and YK2000 were two to four times higher than the MIC in time-kill assay experiments. These results suggest that echinomycin and its analogues might be useful as anti-VRE drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555887     DOI: 10.1016/j.ijantimicag.2004.03.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Isolation and identification of enterococci from seawater samples: assessment of their resistance to antibiotics and heavy metals.

Authors:  Ayten Kimiran-Erdem; Elif Ozlem Arslan; Nazmiye Ozlem Sanli Yurudu; Zuhal Zeybek; Nihal Dogruoz; Aysin Cotuk
Journal:  Environ Monit Assess       Date:  2006-12-14       Impact factor: 2.513

2.  Identification of Enterococcus faecalis bacteria resistant to heavy metals and antibiotics in surface waters of the Mololoa River in Tepic, Nayarit, Mexico.

Authors:  Verónica Alejandra Mondragón; Dámaris F Llamas-Pérez; Gladis E González-Guzmán; Antonio R Márquez-González; Roberto Padilla-Noriega; Ma de Jesús Durán-Avelar; Bernardo Franco
Journal:  Environ Monit Assess       Date:  2011-03-11       Impact factor: 2.513

3.  Interaction of an echinomycin-DNA complex with manganese ions.

Authors:  Roland Pfoh; Jose A Cuesta-Seijo; George M Sheldrick
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-06-27

4.  Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic.

Authors:  Caixia Chen; Xiangyin Chen; Biao Ren; Hui Guo; Wael M Abdel-Mageed; Xueting Liu; Fuhang Song; Lixin Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

Review 5.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

6.  A New Analogue of Echinomycin and a New Cyclic Dipeptide from a Marine-Derived Streptomyces sp. LS298.

Authors:  Xin Zhen; Ting Gong; Fu Liu; Pei-Cheng Zhang; Wan-Qi Zhou; Yan Li; Ping Zhu
Journal:  Mar Drugs       Date:  2015-11-18       Impact factor: 5.118

7.  Exploitation of Potentially New Antibiotics from Mangrove Actinobacteria in Maowei Sea by Combination of Multiple Discovery Strategies.

Authors:  Qin-Pei Lu; Jing-Jing Ye; Yong-Mei Huang; Di Liu; Li-Fang Liu; Kun Dong; Elizaveta A Razumova; Ilya A Osterman; Petr V Sergiev; Olga A Dontsova; Shu-Han Jia; Da-Lin Huang; Cheng-Hang Sun
Journal:  Antibiotics (Basel)       Date:  2019-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.